Format

Send to

Choose Destination
BMC Neurosci. 2010 Apr 30;11:57. doi: 10.1186/1471-2202-11-57.

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.

Author information

1
Department of Chemical Engineering, Arizona State University, Tempe, AZ 85287-6006, USA.

Abstract

BACKGROUND:

Overexpression and abnormal accumulation of aggregated alpha-synuclein (alphaS) have been linked to Parkinson's disease (PD) and other synucleinopathies. alphaS can misfold and adopt a variety of morphologies but recent studies implicate oligomeric forms as the most cytotoxic species. Both genetic mutations and chronic exposure to neurotoxins increase alphaS aggregation and intracellular reactive oxygen species (ROS), leading to mitochondrial dysfunction and oxidative damage in PD cell models.

RESULTS:

Here we show that curcumin can alleviate alphaS-induced toxicity, reduce ROS levels and protect cells against apoptosis. We also show that both intracellular overexpression of alphaS and extracellular addition of oligomeric alphaS increase ROS which induces apoptosis, suggesting that aggregated alphaS may induce similar toxic effects whether it is generated intra- or extracellulary.

CONCLUSIONS:

Since curcumin is a natural food pigment that can cross the blood brain barrier and has widespread medicinal uses, it has potential therapeutic value for treating PD and other neurodegenerative disorders.

PMID:
20433710
PMCID:
PMC2879277
DOI:
10.1186/1471-2202-11-57
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center